IBDEI0Z9 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16240,1,4,0)
 ;;=4^R79.81
 ;;^UTILITY(U,$J,358.3,16240,2)
 ;;=^5019592
 ;;^UTILITY(U,$J,358.3,16241,0)
 ;;=R79.1^^88^844^23
 ;;^UTILITY(U,$J,358.3,16241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16241,1,3,0)
 ;;=3^Coagulation Profile,Abnormal
 ;;^UTILITY(U,$J,358.3,16241,1,4,0)
 ;;=4^R79.1
 ;;^UTILITY(U,$J,358.3,16241,2)
 ;;=^5019591
 ;;^UTILITY(U,$J,358.3,16242,0)
 ;;=R79.82^^88^844^24
 ;;^UTILITY(U,$J,358.3,16242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16242,1,3,0)
 ;;=3^C-Reactive Protein,Elevated
 ;;^UTILITY(U,$J,358.3,16242,1,4,0)
 ;;=4^R79.82
 ;;^UTILITY(U,$J,358.3,16242,2)
 ;;=^331570
 ;;^UTILITY(U,$J,358.3,16243,0)
 ;;=D75.9^^88^844^25
 ;;^UTILITY(U,$J,358.3,16243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16243,1,3,0)
 ;;=3^Blood/Blood-Forming Organ Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16243,1,4,0)
 ;;=4^D75.9
 ;;^UTILITY(U,$J,358.3,16243,2)
 ;;=^5002393
 ;;^UTILITY(U,$J,358.3,16244,0)
 ;;=R97.1^^88^844^26
 ;;^UTILITY(U,$J,358.3,16244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16244,1,3,0)
 ;;=3^Elevated Cancer Antigen 125
 ;;^UTILITY(U,$J,358.3,16244,1,4,0)
 ;;=4^R97.1
 ;;^UTILITY(U,$J,358.3,16244,2)
 ;;=^5019747
 ;;^UTILITY(U,$J,358.3,16245,0)
 ;;=R97.0^^88^844^27
 ;;^UTILITY(U,$J,358.3,16245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16245,1,3,0)
 ;;=3^Elevated Carcinoembryonic Antigen
 ;;^UTILITY(U,$J,358.3,16245,1,4,0)
 ;;=4^R97.0
 ;;^UTILITY(U,$J,358.3,16245,2)
 ;;=^5019746
 ;;^UTILITY(U,$J,358.3,16246,0)
 ;;=R74.0^^88^844^28
 ;;^UTILITY(U,$J,358.3,16246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16246,1,3,0)
 ;;=3^Elevated Liver Function Test
 ;;^UTILITY(U,$J,358.3,16246,1,4,0)
 ;;=4^R74.0
 ;;^UTILITY(U,$J,358.3,16246,2)
 ;;=^5019565
 ;;^UTILITY(U,$J,358.3,16247,0)
 ;;=R97.2^^88^844^29
 ;;^UTILITY(U,$J,358.3,16247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16247,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,16247,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,16247,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,16248,0)
 ;;=D72.1^^88^844^30
 ;;^UTILITY(U,$J,358.3,16248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16248,1,3,0)
 ;;=3^Eosinophilia
 ;;^UTILITY(U,$J,358.3,16248,1,4,0)
 ;;=4^D72.1
 ;;^UTILITY(U,$J,358.3,16248,2)
 ;;=^41173
 ;;^UTILITY(U,$J,358.3,16249,0)
 ;;=R73.09^^88^844^31
 ;;^UTILITY(U,$J,358.3,16249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16249,1,3,0)
 ;;=3^Glucose,Abnormal (HgbA1c)
 ;;^UTILITY(U,$J,358.3,16249,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,16249,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,16250,0)
 ;;=R58.^^88^844^32
 ;;^UTILITY(U,$J,358.3,16250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16250,1,3,0)
 ;;=3^Hemorrhage NEC
 ;;^UTILITY(U,$J,358.3,16250,1,4,0)
 ;;=4^R58.
 ;;^UTILITY(U,$J,358.3,16250,2)
 ;;=^5019528
 ;;^UTILITY(U,$J,358.3,16251,0)
 ;;=E88.09^^88^844^33
 ;;^UTILITY(U,$J,358.3,16251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16251,1,3,0)
 ;;=3^Hypoalbuminemia NEC
 ;;^UTILITY(U,$J,358.3,16251,1,4,0)
 ;;=4^E88.09
 ;;^UTILITY(U,$J,358.3,16251,2)
 ;;=^5003027
 ;;^UTILITY(U,$J,358.3,16252,0)
 ;;=D70.9^^88^844^34
 ;;^UTILITY(U,$J,358.3,16252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16252,1,3,0)
 ;;=3^Neutropenia,Unspec
 ;;^UTILITY(U,$J,358.3,16252,1,4,0)
 ;;=4^D70.9
 ;;^UTILITY(U,$J,358.3,16252,2)
 ;;=^334186
 ;;^UTILITY(U,$J,358.3,16253,0)
 ;;=D72.819^^88^844^35
 ;;^UTILITY(U,$J,358.3,16253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16253,1,3,0)
 ;;=3^White Blood Cell Count,Decreased,Unspec
 ;;^UTILITY(U,$J,358.3,16253,1,4,0)
 ;;=4^D72.819
 ;;^UTILITY(U,$J,358.3,16253,2)
 ;;=^5002376
 ;;^UTILITY(U,$J,358.3,16254,0)
 ;;=D72.829^^88^844^36
